Targeted neurostimulation reverses a spatiotemporal biomarker of treatment-resistant depression
2023 · Proceedings of the National Academy of Sciences · 53 citations
https://doi.org/10.1073/pnas.2218958120
I
Ian H. Kratter
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
36
Papers
598
Citations
12
h-index
15
i10-index
Ian H. Kratter is an academic researcher from Stanford University. The author has contributed to research in topics: Neurological disorders and treatments & Transcranial Magnetic Stimulation Studies & Functional Brain Connectivity Studies. The author has an h-index of 12, co-authored 31 publications.
ORCID: 0000-0001-9122-4525Papers by this author
worksNetwork effects of Stanford Neuromodulation Therapy (SNT) in treatment-resistant major depressive disorder: a randomized, controlled trial
2023 · Translational Psychiatry · 27 citations
https://doi.org/10.1038/s41398-023-02537-9
A preliminary randomized controlled trial of repetitive transcranial magnetic stimulation applied to the left dorsolateral prefrontal cortex in treatment seeking participants with cannabis use disorder
2023 · Drug and Alcohol Dependence · 13 citations
https://doi.org/10.1016/j.drugalcdep.2023.111035
Pilot study of stanford neuromodulation therapy (SNT) for bipolar depression
2024 · Brain stimulation · 7 citations
https://doi.org/10.1016/j.brs.2024.03.002
631. Evaluating Augmentation of Anti-Suicidal Effects of Intravenous Ketamine by Low Oral Doses of Opioid Receptor Partial Agonism
2025 · Biological Psychiatry · 0 citations
https://doi.org/10.1016/j.biopsych.2025.02.870
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat